Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ADD-IT1: A Randomized Study of Adjuncts to Immunotherapy in Patients With Advanced Cancers

NCT07836712 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT07836712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07836712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ADD-IT1: A Randomized Study of Adjuncts to Immunotherapy in Patients With Advanced Cancers
Lead sponsor
University of Southern California
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
November 1, 2028
Enrollment
46 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced hepatocellular carcinoma, advanced melanoma, locally advanced melanoma, metastatic melanoma, stage iii hepatocellular carcinoma ajcc v8, stage iv hepatocellular carcinoma ajcc v8